Summary
Quest Diagnostics Inc. (DGX) reported its second quarter and first half 2019 financial results, showing a modest increase in total net revenues year-over-year. The company's core Diagnostic Information Services (DIS) segment saw revenue growth driven by an increase in requisition volume, partly due to expanded in-network access with major health plans. However, revenue per requisition declined due to reimbursement pressures and increased denials, partially offset by a favorable test mix. While overall revenue showed modest growth, net income and diluted earnings per share from continuing operations attributable to common stockholders decreased compared to the prior year. This decline was influenced by increased interest expenses, higher income tax expenses, and specific charges related to restructuring and system integration initiatives. The company also highlighted a data security incident involving a third-party vendor (AMCA), which, while not directly impacting the company's systems, may affect future operations and collections. Significant cash flow from operations was generated, supporting investments in acquisitions, capital expenditures, share repurchases, and dividends.
Financial Highlights
57 data points| Revenue | $1.95B |
| Cost of Revenue | $1.26B |
| Gross Profit | $688.00M |
| SG&A Expenses | $362.00M |
| Operating Expenses | $1.65B |
| Operating Income | $307.00M |
| Interest Expense | $46.00M |
| Net Income | $226.00M |
| EPS (Basic) | $1.67 |
| EPS (Diluted) | $1.66 |
| Shares Outstanding (Basic) | 135.00M |
| Shares Outstanding (Diluted) | 136.00M |
Key Highlights
- 1Total net revenues increased by 1.8% to $1.95 billion for the three months ended June 30, 2019, compared to the prior year period.
- 2Diagnostic Information Services (DIS) revenue grew by 2.0%, driven by a 4.4% increase in requisition volume, partially offset by a 2.3% decrease in revenue per requisition.
- 3Net income attributable to Quest Diagnostics' common stockholders decreased to $226 million ($1.66 per diluted share) for the quarter, down from $239 million ($1.67 per diluted share) in the prior year.
- 4Net cash provided by operating activities significantly increased to $596 million for the six months ended June 30, 2019, up from $503 million in the prior year.
- 5The company experienced a data security incident involving a third-party vendor (AMCA), which could impact future collections, though the immediate financial impact was not material.
- 6Quest Diagnostics continued its share repurchase program, buying back $100 million of stock in the first six months of 2019, and maintained its quarterly dividend payment.
- 7The company adopted new accounting standards for leases, resulting in the recognition of operating lease assets and liabilities on the balance sheet.